Pharmacological treatment of COVID-19: an opinion paper

The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existi...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Lledó, Alberto, Gómez-Pavón, Javier, del Castillo, Juan González, Hernández-Sampelayo, Teresa, Martín-Delgado, Mari Cruz, Sánchez, Francisco Javier Martín, Martínez-Sellés, Manuel, García, José María Molero, Guillén, Santiago Moreno, Rodríguez-Artalejo, Fernando, Ruiz-Galiana, Julián, Cantón, Rafael, Ramos, Pilar De Lucas, García-Botella, Alejandra, Bouza, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972693/
https://www.ncbi.nlm.nih.gov/pubmed/34894208
http://dx.doi.org/10.37201/req/158.2021
Descripción
Sumario:The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.

Ejemplares similares